BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 15497209)

  • 21. Lack of evidence that p-synephrine is responsible for STEMI.
    Stohs SJ
    Tex Heart Inst J; 2010; 37(3):383; author reply 383-4. PubMed ID: 20548833
    [No Abstract]   [Full Text] [Related]  

  • 22. Safety evaluation of p-synephrine following 15 days of oral administration to healthy subjects: A clinical study.
    Shara M; Stohs SJ; Smadi MM
    Phytother Res; 2018 Jan; 32(1):125-131. PubMed ID: 29130542
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A 60day double-blind, placebo-controlled safety study involving Citrus aurantium (bitter orange) extract.
    Kaats GR; Miller H; Preuss HG; Stohs SJ
    Food Chem Toxicol; 2013 May; 55():358-62. PubMed ID: 23354394
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Subchronic toxicity of Citrus aurantium L. (Rutaceae) extract and p-synephrine in mice.
    Arbo MD; Schmitt GC; Limberger MF; Charão MF; Moro AM; Ribeiro GL; Dallegrave E; Garcia SC; Leal MB; Limberger RP
    Regul Toxicol Pharmacol; 2009 Jul; 54(2):114-7. PubMed ID: 19275924
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synephrine-containing dietary supplement precipitating apical ballooning syndrome in a young female.
    Chung H; Kwon SW; Kim TH; Yoon JH; Ma DW; Park YM; Hong BK
    Korean J Intern Med; 2013 May; 28(3):356-60. PubMed ID: 23682231
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Potential for toxicity with use of bitter orange extract and guarana for weight loss.
    Hess AM; Sullivan DL
    Ann Pharmacother; 2005 Mar; 39(3):574-5. PubMed ID: 15657116
    [No Abstract]   [Full Text] [Related]  

  • 27. Screening for in vivo (anti)estrogenic activity of ephedrine and p-synephrine and their natural sources Ephedra sinica Stapf. (Ephedraceae) and Citrus aurantium L. (Rutaceae) in rats.
    Arbo MD; Franco MT; Larentis ER; Garcia SC; Sebben VC; Leal MB; Dallegrave E; Limberger RP
    Arch Toxicol; 2009 Jan; 83(1):95-9. PubMed ID: 18651134
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Determination of Bitter Orange alkaloids in dietary supplements standard reference materials by liquid chromatography with ultraviolet absorbance and fluorescence detection.
    Putzbach K; Rimmer CA; Sharpless KE; Sander LC
    J Chromatogr A; 2007 Jul; 1156(1-2):304-11. PubMed ID: 17524413
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Concentrations of p-synephrine in fruits and leaves of Citrus species (Rutaceae) and the acute toxicity testing of Citrus aurantium extract and p-synephrine.
    Arbo MD; Larentis ER; Linck VM; Aboy AL; Pimentel AL; Henriques AT; Dallegrave E; Garcia SC; Leal MB; Limberger RP
    Food Chem Toxicol; 2008 Aug; 46(8):2770-5. PubMed ID: 18571300
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reporting associations between dietary supplements and adverse events.
    McGuffin M
    Mayo Clin Proc; 2006 Dec; 81(12):1636; author reply 1636-7. PubMed ID: 17165644
    [No Abstract]   [Full Text] [Related]  

  • 31. Response of CEDIA amphetamines assay after a single dose of bitter orange.
    Nguyen DT; Bui LT; Ambrose PJ
    Ther Drug Monit; 2006 Apr; 28(2):252-4. PubMed ID: 16628139
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Citrus aurantium and synephrine alkaloids in the treatment of overweight and obesity: an update.
    Haaz S; Fontaine KR; Cutter G; Limdi N; Perumean-Chaney S; Allison DB
    Obes Rev; 2006 Feb; 7(1):79-88. PubMed ID: 16436104
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synephrine and Its Derivative Compound A: Common and Specific Biological Effects.
    Dodonova SA; Zhidkova EM; Kryukov AA; Valiev TT; Kirsanov KI; Kulikov EP; Budunova IV; Yakubovskaya MG; Lesovaya EA
    Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139366
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Consumption of dietary supplements containing Citrus aurantium (bitter orange)--2004 California Behavioral Risk Factor Surveillance Survey (BRFSS).
    Klontz KC; Timbo BB; Street D
    Ann Pharmacother; 2006 Oct; 40(10):1747-51. PubMed ID: 16968826
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A case of severe exercise-induced rhabdomyolysis associated with a weight-loss dietary supplement.
    Burke J; Seda G; Allen D; Knee TS
    Mil Med; 2007 Jun; 172(6):656-8. PubMed ID: 17615852
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Availability of weight-loss supplements: Results of an audit of retail outlets in a southeastern city.
    Sharpe PA; Granner ML; Conway JM; Ainsworth BE; Dobre M
    J Am Diet Assoc; 2006 Dec; 106(12):2045-51. PubMed ID: 17126636
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Determination of octopamine, synephrine and tyramine in Citrus herbs by ionic liquid improved 'green' chromatography.
    Tang F; Tao L; Luo X; Ding L; Guo M; Nie L; Yao S
    J Chromatogr A; 2006 Sep; 1125(2):182-8. PubMed ID: 16781718
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A rapid and simple procedure for the determination of synephrine in dietary supplements by gas chromatography-mass spectrometry.
    Marchei E; Pichini S; Pacifici R; Pellegrini M; Zuccaro P
    J Pharm Biomed Anal; 2006 Jun; 41(4):1468-72. PubMed ID: 16698212
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Blood pressure and heart rate effects following a single dose of bitter orange.
    Bui LT; Nguyen DT; Ambrose PJ
    Ann Pharmacother; 2006 Jan; 40(1):53-7. PubMed ID: 16317106
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    Ribeiro DL; Machado ART; Machado C; Ferro Aissa A; Dos Santos PW; Barcelos GRM; Antunes LMG
    J Toxicol Environ Health A; 2021 Mar; 84(5):196-212. PubMed ID: 33292089
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.